Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Max Hoebink, et al, adding:
”Clinical Applicability of Anti-Xa Measurements to Monitor Unfractionated Heparin Activity During Arterial Procedures: A Scoping Review
This scoping review of 55 reports finds that while anti-Xa is a reliable reference test for heparin monitoring during arterial procedures, optimal target levels and their correlation with clinical outcomes remain poorly defined.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Tom Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough